![Case 22-1999 — A 68-Year-Old Woman with Multiple Myeloma, Diabetes Mellitus, and an Inflamed Eye | NEJM Case 22-1999 — A 68-Year-Old Woman with Multiple Myeloma, Diabetes Mellitus, and an Inflamed Eye | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1999/nejm_1999.341.issue-4/nejm199907223410408/production/images/img_medium/nejm199907223410408_t1.jpeg)
Case 22-1999 — A 68-Year-Old Woman with Multiple Myeloma, Diabetes Mellitus, and an Inflamed Eye | NEJM
![Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019) Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)](https://jnccn.org/view/journals/jnccn/17/11.5/full-jnccn20195034f1.jpg)
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)
![The Care and Management of Bisphosphonate – Associated Osteonecrosis of the Jaw in the Patient with Multiple Myeloma: A Case Study | Journal of Dental Hygiene The Care and Management of Bisphosphonate – Associated Osteonecrosis of the Jaw in the Patient with Multiple Myeloma: A Case Study | Journal of Dental Hygiene](https://jdh.adha.org/content/jdenthyg/87/4/181/F2.large.jpg)
The Care and Management of Bisphosphonate – Associated Osteonecrosis of the Jaw in the Patient with Multiple Myeloma: A Case Study | Journal of Dental Hygiene
![Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case Study | National Pharmaceutical Council Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case Study | National Pharmaceutical Council](https://www.npcnow.org/sites/default/files/media/JMCP%2520multiple%2520myeloma.jpg)
Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case Study | National Pharmaceutical Council
![Case Study 35.pptx - Case Study 35 Multiple myeloma (IgG, kappa type) History 54 year old female. One year history of fatigue, weight loss, | Course Hero Case Study 35.pptx - Case Study 35 Multiple myeloma (IgG, kappa type) History 54 year old female. One year history of fatigue, weight loss, | Course Hero](https://www.coursehero.com/thumb/60/7c/607c7af487277af74576e7105d9c89ce1b1b0383_180.jpg)
Case Study 35.pptx - Case Study 35 Multiple myeloma (IgG, kappa type) History 54 year old female. One year history of fatigue, weight loss, | Course Hero
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
![A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? - Markovic - 2019 - Clinical Case Reports - Wiley Online Library A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? - Markovic - 2019 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/10046c5f-9758-45f5-ab55-f52bca10bf58/ccr32292-toc-0001-m.jpg?trick=1666311404288)
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? - Markovic - 2019 - Clinical Case Reports - Wiley Online Library
![Multiple Myeloma Hub on Twitter: "CONGRESS|#EHA2021|@szusmani & Leo Rasche discussed that pts experiencing their 2nd relapse are a very heterogeneous population. Decisions need to be made based on pts characteristics. Case studies, Multiple Myeloma Hub on Twitter: "CONGRESS|#EHA2021|@szusmani & Leo Rasche discussed that pts experiencing their 2nd relapse are a very heterogeneous population. Decisions need to be made based on pts characteristics. Case studies,](https://pbs.twimg.com/media/E4BjMg9VIAIwUzL.jpg)
Multiple Myeloma Hub on Twitter: "CONGRESS|#EHA2021|@szusmani & Leo Rasche discussed that pts experiencing their 2nd relapse are a very heterogeneous population. Decisions need to be made based on pts characteristics. Case studies,
![Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality | Blood Cancer Journal Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-00372-5/MediaObjects/41408_2020_372_Fig1_HTML.png)
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality | Blood Cancer Journal
![Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019) Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)](https://jnccn.org/view/journals/jnccn/17/11.5/inline-jnccn20195034f3.jpg)